keyword
https://read.qxmd.com/read/37489541/the-nutritional-impact-of-cd19-targeted-car-t-therapy-versus-beam-chemotherapy-for-adult-patients-with-lymphoma
#1
JOURNAL ARTICLE
Katie Ahern, James Pham, Robin Sanderson, Madson Correia De Farias, Kevin Walsh
BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy is a novel therapy demonstrating durable remissions in patients with refractory or relapsing non-Hodgkin's B-cell lymphoma. Maintaining a patient's nutritional status has been demonstrated to improve outcomes in cancer treatment. However, no studies have investigated how CAR-T therapy affects nutritional status, nor compared its impact with other cancer treatments for this patient group. The primary aim of the present study was to investigate the effect of CAR-T therapy on the prevalence of nutrition impact symptoms (NIS) and nutritional status within 30 days post-treatment of patients with lymphoma compared to a conditioning regimen for autologous haematopoetic stem cell transplant (carmustine/BCNU, Etoposide, cytarabine/Ara-C, Melphalan [BEAM] auto-haematopoetic stem cell transplant [HSCT])...
July 25, 2023: Journal of Human Nutrition and Dietetics: the Official Journal of the British Dietetic Association
https://read.qxmd.com/read/37296153/asymptomatic-immunodeficiency-associated-vaccine-derived-poliovirus-infections-in-two-uk-children
#2
JOURNAL ARTICLE
Anika Singanayagam, Dimitra Klapsa, Shirelle Burton-Fanning, Julian Hand, Thomas Wilton, Laura Stephens, Ryan Mate, Benjamin Shillitoe, Cristina Celma, Mary Slatter, Terry Flood, Robin Gopal, Javier Martin, Maria Zambon
Increasing detections of vaccine-derived poliovirus (VDPV) globally, including in countries previously declared polio free, is a public health emergency of international concern. Individuals with primary immunodeficiency (PID) can excrete polioviruses for prolonged periods, which could act as a source of cryptic transmission of viruses with potential to cause neurological disease. Here, we report on the detection of immunodeficiency-associated VDPVs (iVDPV) from two asymptomatic male PID children in the UK in 2019...
June 9, 2023: Nature Communications
https://read.qxmd.com/read/36689930/complications-and-utility-of-gastrointestinal-endoscopy-post-hematopoietic-stem-cell-transplantation-an-11-year-experience
#3
JOURNAL ARTICLE
Joseph Chan, Vasiliki Ganosi, Dharamveer Basude, Oana C Mirci-Danicar, Anthony E Wiskin
OBJECTIVES: Diagnostic gastrointestinal (GI) endoscopy is used to differentiate GI graft versus host disease (GI-GvHD), which requires escalation of immunosuppressive treatment (IST), from other conditions such as viral infection, which may require reduction of IST. The aim of this study was to establish the clinical utility of GI endoscopy post hematopoietic stem cell transplant (HSCT) and the complication rate of these procedures. METHODS: This was a single-center observational retrospective cohort study...
April 1, 2023: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/36284212/engraftment-syndrome-after-allogeneic-stem-cell-transplantation-a-systematic-review-and-meta-analysis
#4
REVIEW
Ghada ElGohary, Amir A Toor, Usama Gergis
Engraftment syndrome (ES) is associated with neutrophil recovery after stem cell transplantation (SCT). It is associated with autologous and allogeneic SCT. However, a literature review has shown that allogeneic SCT (allo-SCT) is associated with ES without conclusive data on risk factors or effects on outcomes. This meta-analysis was undertaken to estimate the cumulative incidence of ES following allo-SCT, and to evaluate the risk factors and outcomes among patients with ES following allo-SCT. Current literature was searched using electronic databases, and manually...
January 2023: Bone Marrow Transplantation
https://read.qxmd.com/read/35903096/epstein-barr-virus-reactivation-after-paediatric-haematopoietic-stem-cell-transplantation-risk-factors-and-sensitivity-analysis-of-mathematical-model
#5
JOURNAL ARTICLE
Soumya P Kania, Juliana M F Silva, Oscar J Charles, John Booth, S Y Amy Cheung, James W T Yates, Austen Worth, Judith Breuer, Nigel Klein, Persis J Amrolia, Paul Veys, Joseph F Standing
Epstein-Barr virus (EBV) establishes a lifelong latent infection in healthy humans, kept under immune control by cytotoxic T cells (CTLs). Following paediatric haematopoetic stem cell transplantation (HSCT), a loss of immune surveillance leads to opportunistic outgrowth of EBV-infected cells, resulting in EBV reactivation, which can ultimately progress to post-transplant lymphoproliferative disorder (PTLD). The aims of this study were to identify risk factors for EBV reactivation in children in the first 100 days post-HSCT and to assess the suitability of a previously reported mathematical model to mechanistically model EBV reactivation kinetics in this cohort...
2022: Frontiers in Immunology
https://read.qxmd.com/read/35663681/infection-as-a-differential-diagnosis-of-solid-retroperitoneal-masses-a-case-series-and-review-of-the-literature
#6
Georgia Levidou, Tilman Klein, Kerstin Schaefer-Eckart, Clemens Huettenbrink, Panagiota Manava
The differential diagnosis of retroperitoneal masses includes a variety of benign and malignant conditions, among which infections constitute a significant subgroup. Familiarity with these infectious pseudotumours could facilitate prompt diagnosis. In this report, we describe three patients with an infectious pseudotumour, which was clinically and radiologically highly suggestive of a neoplasm. The first patient was a 62-year-old woman with a history of Richter syndrome, who seven months after allogeneic haematopoetic stem cell transplantation from an unrelated donor presented with a renal mass...
May 2022: Curēus
https://read.qxmd.com/read/34994053/quantiferon-cytomegalovirus-to-predict-clinically-significant-cytomegalovirus-infection-after-allogeneic-hematopoietic-stem-cell-transplantation
#7
JOURNAL ARTICLE
Grace Thompson, Peter Boan, Duncan Purtill, Julian Cooney, Paul Cannell, Matthew Wright, Mina John
BACKGROUND: Controlling cytomegalovirus (CMV) infection through prophylaxis or pre-emptive therapy remains an important contributor to outcomes after allogeneic hematopoetic stem cell transplant (alloHCT). Predicting clinically significant CMV infection (csCMVi) after day 100 remains a challenge. METHODS: We examined the abilty of the QuantiFERON-CMV assay (QFN-CMV) at day 100 (d100) and day 150 (d150) after alloHCT to predict csCMVi after these time points, with median follow-up of 3...
January 6, 2022: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/34969238/raeb-ii-type-of-myelodysplastic-syndrome-associated-with-axillary-abscesses-case-report
#8
Bożena Sokołowska, Daria Majowicz, Magdalena Kozioł, Olga Czabak, Ewa Wąsik-Szczepanek, Adrian Juda, Maria Soroka-Wojtaszko, Marek Hus
Myelodysplastic syndromes (MDS) are clonal haematopoetic stem cells disorders, characterized by bone marrow dysplasia, ineffecitive haematopoesis and cytopenias. Due to neutropenia, infections are common. A case is presented of a patient with high-risk myelodysplastic syndrome (MDS) complicated by hidradenitis suppurativa that developed in both axillae. Abscesses required multiple incisions and drainage. After five cycles of treatment with azacitidine, the patient underwent allogenic bone marrow transplantation...
December 29, 2021: Annals of Agricultural and Environmental Medicine: AAEM
https://read.qxmd.com/read/34294480/long-term-survivors-following-autologous-haematopoetic-stem-cell-transplantation-have-significant-defects-in-their-humoral-immunity-against-vaccine-preventable-diseases-years-on-from-transplant
#9
JOURNAL ARTICLE
Hayley Colton, Diana M Greenfield, John A Snowden, Paul D E Miller, Nicholas J Morley, Josh Wright, Thomas C Darton, Cariad M Evans, Thushan I de Silva
Current international guidelines recommend routinely vaccinating haematopoetic stem cell transplant (HSCT) recipients. Despite significant infection-related mortality following autologous HSCT, routine vaccination programmes (RVP) completion is poor. For recovered HSCT recipients, it is uncertain whether catch-up vaccination remains worthwhile years later. To determine potential susceptibility to vaccine preventable infections, we measured antibody titres in 56 patients, a median of 7 years (range 0-29) following autologous HSCT, who had not completed RVP...
July 19, 2021: Vaccine
https://read.qxmd.com/read/33971817/dr2s-an-integrated-algorithm-providing-reference-grade-haplotype-sequences-from-heterozygous-samples
#10
JOURNAL ARTICLE
Steffen Klasberg, Alexander H Schmidt, Vinzenz Lange, Gerhard Schöfl
BACKGROUND: High resolution HLA genotyping of donors and recipients is a crucially important prerequisite for haematopoetic stem-cell transplantation and relies heavily on the quality and completeness of immunogenetic reference sequence databases of allelic variation. RESULTS: Here, we report on DR2S, an R package that leverages the strengths of two sequencing technologies-the accuracy of next-generation sequencing with the read length of third-generation sequencing technologies like PacBio's SMRT sequencing or ONT's nanopore sequencing-to reconstruct fully-phased high-quality full-length haplotype sequences...
May 10, 2021: BMC Bioinformatics
https://read.qxmd.com/read/33377884/autologous-bone-marrow-transplant-in-multiple-myeloma-patient-with-bone-marrow-hematopoietic-stem-cell
#11
JOURNAL ARTICLE
D Santosa, Catharina Suharti, Edi Dharmana
Multiple myeloma (MM) is a malignancy with multiple complications such as recurrent bacterial infections, anemia, osteolytic lesions, bone marrow failure and decreased kidney function. In developed transplant center, the bone marrow transplant procedure is performed by the source of peripheral blood stem cells. Apheresis machine which is not always available in all Haematology and Oncology Centre in Indonesia, is required for harvesting stem cell from PBSC (peripheral blood stem cell). There are only a few reports on marrow-derived stem cells transplant from BM with a 24-hour storage in multiple myeloma cases...
October 2020: Acta Medica Indonesiana
https://read.qxmd.com/read/33357480/lenalidomide-maintenance-after-autologous-haematopoietic-stem-cell-transplantation-in-mantle-cell-lymphoma-results-of-a-fondazione-italiana-linfomi-fil-multicentre-randomised-phase-3-trial
#12
RANDOMIZED CONTROLLED TRIAL
Marco Ladetto, Sergio Cortelazzo, Simone Ferrero, Andrea Evangelista, Michael Mian, Rita Tavarozzi, Manuela Zanni, Federica Cavallo, Alice Di Rocco, Vittorio Stefoni, Chiara Pagani, Alessandro Re, Annalisa Chiappella, Monica Balzarotti, Vittorio R Zilioli, Maria Gomes da Silva, Luca Arcaini, Anna L Molinari, Filippo Ballerini, Andrés J M Ferreri, Benedetta Puccini, Fabio Benedetti, Piero M Stefani, Franco Narni, Ivana Casaroli, Caterina Stelitano, Giovannino Ciccone, Umberto Vitolo, Maurizio Martelli
BACKGROUND: Fit patients with mantle cell lymphoma aged 18-65 years are usually given cytarabine and rituximab-based induction regimens followed by autologous haematopoetic stem-cell transplantation (HSCT). We investigated whether post-autologous HSCT maintenance with lenalidomide improves progression-free survival in this population. METHODS: This open-label, randomised, multicentre, phase 3 trial was done at 49 haematology and oncology units in Italy and Portugal...
January 2021: Lancet Haematology
https://read.qxmd.com/read/33127497/the-challenge-of-using-the-virtual-crossmatch-as-a-singular-tool-for-the-detection-of-anti-hla-antibodies-a-study-from-a-tertiary-care-institute-from-south-india
#13
JOURNAL ARTICLE
Snehil Kumar, Sam Arul Doss, S Stephen, M Pratheeba, L Jeyaseelan, Dolly Daniel
INTRODUCTION: Detection of donor specific antibodies (DSA) is critical in both solid organ and mismatched haematopoietic stem cell transplants. The single antigen bead assay (SAB) is widely used as a virtual crossmatch in these settings. However, HLA allele variation across ethnicities and differing genetic backgrounds is a well-known and acknowledged fact and representation of alleles prevalent in a population is key while using a virtual crossmatch as a sole decision making tool. Against this background, this study was performed to assess the feasibility of using the SAB as a single tool to identify DSA in our population...
April 2021: Transplant Immunology
https://read.qxmd.com/read/32849540/cd70-deficiency-associated-with-chronic-epstein-barr-virus-infection-recurrent-airway-infections-and-severe-gingivitis-in-a-24-year-old-woman
#14
Renate Krüger, Emmanuel Martin, Jasmin Dmytrus, Cornelia Feiterna-Sperling, Christian Meisel, Nadine Unterwalder, Uwe Kölsch, Volker Wahn, Jörg Hofmann, Paula Korn, Sylvain Latour, Kaan Boztug, Horst von Bernuth
Most of the few patients with homozygous CD70 deficiency described to date suffered from EBV-related malignancies in early childhood. We present a woman with CD70 deficiency diagnosed in adulthood. She presented in childhood with recurrent airway infections due to encapsulated bacteria, herpes zoster and a fulminant EBV infection followed by chronic EBV infection with mild lymphoproliferation and severe gingivitis/periodontal disease with high EBV viral load in saliva and gingival plaques as an adult. Up to the age of 24 years she developed no malignancy despite constant EBV viremia since primary EBV infection 15 years previously...
2020: Frontiers in Immunology
https://read.qxmd.com/read/32296434/diagnosis-and-management-of-secondary-hlh-mas-following-hsct-and-car-t-cell-therapy-in-adults-a-review-of-the-literature-and-a-survey-of-practice-within-ebmt-centres-on-behalf-of-the-autoimmune-diseases-working-party-adwp-and-transplant-complications-working
#15
REVIEW
Robert David Sandler, Rachel Scarlett Tattersall, Helene Schoemans, Raffaella Greco, Manuela Badoglio, Myriam Labopin, Tobias Alexander, Kirill Kirgizov, Montserrat Rovira, Muhammad Saif, Riccardo Saccardi, Julio Delgado, Zinaida Peric, Christian Koenecke, Olaf Penack, Grzegorz Basak, John Andrew Snowden
Introduction: Secondary haemophagocytic lymphohistiocytosis (sHLH) or Macrophage Activation Syndrome (MAS) is a life-threatening hyperinflammatory syndrome that can occur in patients with severe infections, malignancy or autoimmune diseases. It is also a rare complication of haematopoetic stem cell transplantation (HSCT), with a high mortality. It may be associated with graft vs. host disease in the allogeneic HSCT setting. It is also reported following CAR-T cell therapy, but differentiation from cytokine release syndrome (CRS) is challenging...
2020: Frontiers in Immunology
https://read.qxmd.com/read/32073158/population-pharmacokinetics-and-bayesian-estimators-for-intravenous-mycophenolate-mofetil-in-haematopoietic-stem-cell-transplant-patients
#16
JOURNAL ARTICLE
Marc Labriffe, Julien Vaidie, Caroline Monchaud, Jean Debord, Pascal Turlure, Stephane Girault, Pierre Marquet, Jean-Baptiste Woillard
AIMS: Intravenous mycophenolate mofetil (IV MMF), a prodrug of mycophenolic acid (MPA), is used during non-myeloablative and reduced-intensity conditioning haematopoetic stem cell transplantation (HCT) to improve engraftment and reduce graft-versus-host disease. The aims of this study were to develop population pharmacokinetic models and Bayesian estimators based on limited sampling strategies, to allow for individual dose adjustment of intravenous mycophenolate mofetil administered by infusion in haematopoietic stem cell transplant patients...
February 19, 2020: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/31078634/lipocalin-2-levels-in-acute-and-chronic-graft-versus-host-disease-following-allogeneic-haematopoietic-stem-cell-transplantation
#17
JOURNAL ARTICLE
Alexander Hermann, Andreas Winkler, Christopher Paschen, Zoya Kuzmina, Anastasiya Hladik, Süphan Icme, Oliver Robak
Lipocalin-2 (LCN2) is an immunomodulatory protein holding major metabolic and immune functions. It is involved in several inflammatory processes and induced by cytokines of the IL-1 family known as contributors to the morbidity in graft-versus-host disease (GVHD) following haematopoetic stem cell transplantation (HSCT). The possible role of LCN2 in predicting outcome and course of illness has never been elucidated in patients undergoing HSCT for haematologic malignancies. We conducted a prospective cohort study including 40 patients following autologous or allogeneic HSCT by collecting plasma samples at 7 timepoints with regards to GVHD, relapse, and outcome...
May 9, 2019: Experimental Hematology
https://read.qxmd.com/read/30907098/-impact-of-minimal-residual-disease-detection-after-treatment-of-multiple-myeloma
#18
JOURNAL ARTICLE
Tamás Szendrei, Márk Plander, Zsuzsanna Szabó, László Kereskai, Béla Kajtár, Gergely Papp, János László Iványi
INTRODUCTION: Prognostic impact of the detection of minimal residual disease (MRD) in multiple myeloma (MM) has been confirmed in numerous studies. AIM: Retrospective examination of our patient database (107 newly diagnosed multiple myelomas between 2007 and 2017). Flow cytometry (FCM) was performed as MRD assessment. METHOD: MRD assessment was performed in 56 patients (median age: 68 years), after induction treatment of multiple myeloma. The treatment contained bortezomib in 91%, autologous haematopoetic stem cell transplantation (ASCT) was perfomed in 50%...
March 2019: Orvosi Hetilap
https://read.qxmd.com/read/28904635/does-orthopaedic-surgery-improve-quality-of-life-and-function-in-patients-with-mucopolysaccharidoses
#19
JOURNAL ARTICLE
N Williams, D Challoumas, D M Eastwood
PURPOSE: Mucopolysaccharidoses (MPS) are a group of rare lysosomal storage disorders associated with involvement of multiple organs along with a generalised skeletal dysplasia. Both haematopoetic stem cell transplant and enzyme replacement therapy have improved the outlook for patients while surgery remains high-risk and there is little information on clinical or functional outcome to justify many of the surgical procedures performed. This paper aims to summarise the orthopaedic surgical procedures in MPS patients for which quality of life (QoL) and functional data are available and to describe additional QoL and functional measurement tools of relevance to the assessment of orthopaedic outcomes in MPS...
August 1, 2017: Journal of Children's Orthopaedics
https://read.qxmd.com/read/28869416/autologous-stem-cell-transplantation-in-systemic-sclerosis-a-systematic-review
#20
REVIEW
Lauren Host, Mandana Nikpour, Alicia Calderone, Paul Cannell, Janet Roddy
OBJECTIVES: Haematopoetic autologous stem cell transplantation (ASCT) has emerged as a treatment option for patients with refractory, severe autoimmune disease. This is a systematic review of the current literature on ASCT in adult patients with systemic sclerosis (SSc). METHODS: Original articles published between 2005 and 2016 that evaluated the use of ASCT in patients with SSc were reviewed with respect to the primary outcomes of overall and transplant related mortality (TRM) rates, and secondary outcomes of changes in modified Rodnan Skin Score (mRSS), forced vital capacity (FVC), progression/event free survival (P/EFS) and quality of life measures...
September 2017: Clinical and Experimental Rheumatology
keyword
keyword
41552
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.